Ultime notizie per Limoneira (NASDAQ:LMNR) Azioni

Limoneira

Limoneira Co is an agribusiness company. The company's operating segments include Fresh Lemons; Lemon Packing; Avocados and Other Agribusiness. It generates maximum revenue from the Fresh Lemons segment.

Limoneira Co

Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) has significantly <a href="https://www.benzinga.com/markets/equities/23/12/36046659/why-citrus-fruits-company-limoneiras-shares-are-seeing-blue-skies-today">raised its expectations</a> on avocado volumes this year to take advantage of higher prices for the fruit.
&#8220;We now expect avocado volumes to be in the range of 14.5 million to 15.5 million pounds for fiscal year 2024 compared to previous guidance of 9 million to 10 million pounds, a more than 50% increase compared to prior guidance,&#8221; CEO Harold Edwards said on Monday during a third-quarter earnings call with analysts.
&#8220;We expect to complete the avocado harvest in the fourth quarter with approximately 4 million to 5 million pounds remaining. Keep in mind, we expect our fourth quarter to represent a record in avocado volume due to our timing and ability to hold the fruit to match a higher pricing environment.&#8221;
The company recorded $13.9 million&nbsp;of avocado revenue in the third quarter of fiscal year 2024, compared to&nbsp;$3.5 million&nbsp;in the third quarter of last fiscal year. 
Read Also: <a href="https://www.benzinga.com/general/24/05/39029025/avocado-toast-isnt-the-problem-gen-z-faces-maximum-credit-card-debt-and-lower-earnings-compared-to-a">Avocado Toast Isn&#8217;t The Problem: Gen Z Faces Maximum Credit Card Debt And Lower Earnings Compared To Any Other Generation, Finds The Fed</a>
About 8.86 million pounds of avocados were sold in aggregate during the third quarter of fiscal year 2024 at a&nbsp;$1.57&nbsp;average price per pound, compared to approximately 2.82 million pounds sold at a&nbsp;$0.99&nbsp;average price per pound during the third quarter of fiscal year 2023.
Limoneira posted $63.3 million in net revenue for this year&#8217;s third quarter, up from $52.5 million a year ago.
Limoneira expects to expand avocado production by 1,000 acres over the next three years to take advantage of robust consumer demand but expects volume to be lower next year as a result of the yearly alternate bearing nature of avocado trees, CFO Mark Palamountain said.
The company expects avocado pricing to be lower in 2025 despite forecasting lower volume that year, he said.
&#8220;The company believes avocado pricing may be slightly lower compared to the current year pricing environment due to international circumstances,&#8221; he said.
Price Action: Shares of Limoneira were down 3.2% to $24.20 at the time of publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/real-estate/24/06/39182926/dont-blame-the-avocado-toast-millennials-and-gen-z-getting-better-mortgage-rates">Don&#8217;t Blame The Avocado Toast: Millennials And Gen Z Getting Better Mortgage Rates</a></li>
</ul>
Photo: OlgaBombologna/Shutterstock.com

Earnings

LMNR

Why Avocado Toast May Get A Lot Cheaper

Lake Street analyst Ben Klieve downgrades Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) from Buy to Hold and maintains the price target from $25 to $25.

News

Downgrades

Price Target

Analyst Ratings

Lake Street Downgrades Limoneira to Hold, Maintains Price Target to $25

The Company now expects avocado volumes to be in the range of 14.5 million to 15.5 million pounds for fiscal year 2024, compared to previous&nbsp;guidance&nbsp;of 9.0 million to 10.0 million pounds, a more than&nbsp;50%&nbsp;increase compared to prior&nbsp;guidance.&nbsp;
The Company now expects fresh lemon volumes to be in the range of 4.5 million to 5.0 million cartons for fiscal year 2024, compared to previous&nbsp;guidance&nbsp;of 5.0 million to 5.5 million cartons, due to lower fresh utilization from late season rains. The lemon harvest for fiscal year 2024 is approximately&nbsp;85%&nbsp;complete.

Guidance

Limoneira Boosts Avocado Volume Guidance For FY24; Expects FY25 Avocado Volume To Be Lower Y/Y Due To The Alternate Bearing Nature Of Avocado Trees

Limoneira Says Strategic Alternatives Exploration To Maximize Stockholder Value Continues To Progress

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly earnings of $0.42 per share which beat the analyst consensus estimate of $0.34 by 23.53 percent. This is a 2000 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $63.30 million which missed the analyst consensus estimate of $63.57 million by 0.41 percent. This is a 20.59 percent increase over sales of $52.50 million the same period last year.

Earnings Beats

Earnings Misses

Limoneira Q3 2024 Adj EPS $0.42 Beats $0.34 Estimate, Sales $63.30M Miss $63.57M Estimate

B. Riley Securities maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $24 to $28.

B. Riley Securities Maintains Buy on Limoneira, Raises Price Target to $28

WIIM

Limoneira shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its guidance. Also, Lake Street maintained a Buy rating on the stock and raised its price target from $23 to $25.

Looking ahead, the Company is raising its outlook for non-GAAP EBITDA accretion to a range of $45 million to $55 million by fiscal year 2030, up from its previous target of $30 million. This increase is underpinned by plans to significantly expand avocado production by 1,000 acres over the next three years to capitalize on robust consumer demand trends. During this transition, the Company expects FY 2025 and FY 2026 operational results to be similar to FY 2024. These operational results do not take into account expected additional earnings from Harvest at Limoneira.

Limoneira Said It Is Raising Its Outlook For Non-GAAP EBITDA Accretion To A Range Of $45M-$55M By Fiscal Year 2030, Up From Its Previous Target Of $30M

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly earnings of $0.44 per share which beat the analyst consensus estimate of $0.18 by 144.44 percent. The company reported quarterly sales of $44.606 million which missed the analyst consensus estimate of $53.963 million by 17.34 percent. This is a 7.21 percent decrease over sales of $48.070 million the same period last year.

Thursday June 6, 2024 Limoneira Reported Q2 Adj EPS $0.44 Beats $0.18 Estimate, Sales $44.606M Miss $53.963M Estimate

Lake Street analyst Ben Klieve maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $23 to $25.

Lake Street Maintains Buy on Limoneira, Raises Price Target to $25

U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Friday.
Shares of Argan, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) rose sharply during Friday's session after the company reported better-than-expected <a href="https://www.benzinga.com/quote/AGX/earnings">first-quarter financial results</a>.
Argan posted quarterly earnings of 58 cents per share, beating market estimates of 52 cents per share. The company's quarterly sales came in at $157.68 million versus expectations of $134.75 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Argan shares climbed 11.1% to $76.78 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>Geron Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GERN#NASDAQ">GERN</a>) shares climbed 26% to $4.90 as the company reported the FDA approval of RYTELO&#x2122; (imetelstat), a first-in-class telomerase inhibitor, for the treatment of adult patients with lower-risk MDS with transfusion-dependent anemia.</li>
<li>SunPower Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPWR#NASDAQ">SPWR</a>) shares jumped 18.8% to $4.11.</li>
<li>Oddity Tech Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ODD#NASDAQ">ODD</a>) rose 18.3% to $43.49 after the company approved a share buyback and raised its Q2 guidance.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) climbed 14.7% to $5.42. Yext is said to hire investment bankers to explore strategic alternatives, including a sale, Reuters reported.</li>
<li>Planet Labs PBC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PL#NYSE">PL</a>) climbed 9.6% to $1.9950 following better-than-expected quarterly earnings.</li>
<li>Limoneira Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) gained 9.4% to $22.27 as the company reported financial results for the second quarter ended April 30, 2024.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) gained 8.7% to $2.6850.</li>
<li>Waldencast plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) rose 8.6% to $4.77.</li>
<li>NWTN Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) climbed 8.5% to $2.17.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) gained 7.8% to $39.57. B. Riley Securities analyst Hal Goetsch initiated coverage on Dave with a Buy rating and announced a price target of $60.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) rose 7.6% to $29.48.</li>
<li>Credo Technology Group Holding Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NASDAQ">CRDO</a>) gained 7.2% to $27.72.</li>
<li>Braze, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) gained 4.2% to $38.32 following better-than-expected first-quarter earnings.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 3.7% to $108.49.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39227364/this-exxon-mobil-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday">This Exxon Mobil Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday</a>

Intraday Update

Markets

Movers

Trading Ideas

BRZE

CRDO

CVNA

DAVE

ESPR

GERN

MBLY

NWTN

SPWR

WALD

YEXT

Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday

Hormel Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrl#NYSE">HRL</a>) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.40 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 8.57%. A quarter ago, it was expected that this maker of Spam canned ham, Dinty Moore stew and other foods would post earnings of $0.34 per share when it actually produced earnings of $0.41, delivering a surprise of 20.59%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.
Hormel, which belongs to the Zacks Food - Meat Products industry, posted revenues of $2.89 billion for the quarter ended April 2024, missing the Zacks Consensus Estimate by 3.35%. This compares to year-ago revenues of $2.98 billion. The company has topped consensus revenue estimates just once over the last four quarters.
The sustainability of the stock&#39;s immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management&#39;s commentary on the earnings call.
Hormel shares have added about 6.2% since the beginning of the year versus the S&amp;P 500&#39;s gain of 10.4%.
What&#39;s Next for Hormel?
While Hormel has underperformed the market so far this year, the question that comes to investors&#39; minds is: what&#39;s next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company&#39;s earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Hormel: mixed. While the magnitude and direction of estimate revisions could change following the company&#39;s just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.38 on $3.01 billion in revenues for the coming quarter and $1.59 on $12.26 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Food - Meat Products is currently in the top 22% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Limoneira (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmnr#NASDAQ">LMNR</a>), another stock in the broader Zacks Consumer Staples sector, has yet to report results for the quarter ended April 2024. The results are expected to be released on June 6.
This agribusiness company is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Limoneira&#39;s revenues are expected to be $54.62 million, up 13.6% from the year-ago quarter.
<a href="https://www.zacks.com/stock/news/2281110/hormel-foods-hrl-q2-earnings-beat-estimates?cid=CS-BENZ-FT-tale_of_the_tape|yseop_template_4-2281110">To read this article on Zacks.com click here.</a>

Small Cap

Hormel Foods Q2 Earnings Beat Estimates

Total Number of Entitled Lots for the Development Project Grows 37% from 1,500 Dwelling Units to 2,050 Dwelling Units
Limoneira Increases Phase 3 of Harvest at Limoneira by 250 Single-Family Homesites and Adds 300 Rental Homes to the Project
Limoneira Company (the "Company" or "Limoneira") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, announced today that the Santa Paula City Council has approved the proposal brought forward by the Company's real estate development joint venture with The Lewis Group of Companies ("Lewis") to increase the number of entitled lots in the Harvest at Limoneira master planned community ("Harvest") from 1,500 dwelling units to 2,050 dwelling units. The Santa Paula City Council approved an amendment allowing for the 550 unit increase on April 3, 2024. The 550-unit increase will provide 250 additional single family for-sale homesites within Phase 3 of Harvest. Additionally, the Company in partnership with Lewis plans to construct 300 multi-family rental homes on a mixed-use portion of the project. The last lot sales in Phase 1 of Harvest closed back in October of 2023. Phase 1 is comprised of 707 residential units, 586 of which have already been sold to home buyers and the remaining 121 will be constructed by Lennar and Richmond American Homes. Phase 2 of Harvest closed on April 30, 2024, and is comprised of 554 residential homesites.
Harold Edwards, President and Chief Executive Officer of the Limoneira Company, stated, "We appreciate the Santa Paula City Council's continued support of what we are trying to achieve at Harvest and believe their approval to increase the total number of units speaks to the excellent value our development project brings to the city. We honor our tradition of being great stewards, not only to the land we cultivate but also to our community and believe this is the reason we have been one of only two real estate development projects in Ventura County to receive approval via a SOAR vote. We plan to provide an update to our anticipated cash flow projections for Harvest at Limoneira when we release our second quarter financial results in June."
Harvest at Limoneira is a well-balanced, comprehensively designed community providing a range of new housing options near the Pacific Ocean. Boasting scenic views, and close proximity to parks, hiking trails and popular retail destinations, this exceptional community continues to attract strong interest from new home buyers throughout Southern California.

Limoneira's Joint Venture With Lewis Group Of Companies Announces Approval For Additional 550 Dwelling Units In Harvest At Limoneira Development Project

Phase 2 Closing Consists of 554 Homesites in Harvest; All Acquired by Lennar
Joint Venture Has Now Closed a Total of 1,261 Residential Homesite Sales at Harvest
Limoneira Company (the "Company" or "Limoneira") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>), a diversified citrus growing, packing, selling and marketing company with related agribusiness activities and real estate development operations, announced today that its real estate development joint venture with The Lewis Group of Companies ("Lewis") has closed an additional 554 residential homesites at their Harvest at Limoneira master planned community in Santa Paula ("Harvest"). These homesites were purchased by Lennar, one of the primary builders in Phase 1 of Harvest, and completes the sell-out of Phase 2 of Harvest. Phase 2 is the Foothill Neighborhood, consisting of seven different lot types with home sizes ranging from approximately 1,500 to 3,500 square feet. The Foothill Neighborhood will include at least 20 various floor plans utilizing distinctive architectural elevations and some of the homes will include unique views of the Pacific Ocean.
Harold Edwards, President and Chief Executive Officer of the Limoneira Company, stated, "We are very pleased to announce the completion of the sale of Phase 2 at Harvest with the sale of all 554 homesites to Lennar. Lennar was one of the guest builders within Phase 1 and we are excited that they have committed to being the sole builder for Phase 2. We will be able to provide an update on profitability of this transaction and actual cash to be received by Limoneira in fiscal 2024 with our earnings announcement in June."
Including today's announcement, Lennar has now purchased a total of 867 single-family homesites within Harvest, 313 homesites in Phase 1 and 554 homesites in Phase 2.
Harvest at Limoneira is a well-balanced, comprehensively designed community providing a range of new housing options near the Pacific Ocean. Boasting scenic views, and close proximity to parks, hiking trails and popular retail destinations, this exceptional community continues to attract strong interest from new home buyers throughout Southern California.

Biotech

General

Limoneira's Joint Venture With The Lewis Group Of Companies Announces The Closing For All Of Phase 2 At Harvest At Limoneira With National Home Builder Lennar

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported its Q1 earnings results on Thursday, March 7, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Limoneira beat estimated earnings by 38.0%, reporting an EPS of $-0.18 versus an estimate of $-0.29.
Revenue was up $1.83 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 7.000000000000001% increase in the share price the next day.
Here's a look at Limoneira's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.15</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>37.82M</td>
<td>50.07M</td>
<td>48.24M</td>
<td>37.71M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>41.43M</td>
<td>52.50M</td>
<td>48.07M</td>
<td>37.90M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Limoneira <a href="https://www.benzinga.com/quote/LMNR/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: Limoneira Q1 Earnings

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) reported quarterly losses of $(0.180) per share which beat the analyst consensus estimate of $(0.270) by 33.33 percent. The company reported quarterly sales of $39.731 million which missed the analyst consensus estimate of $40.581 million by 2.10 percent. This is a 4.83 percent increase over sales of $37.901 million the same period last year.

Limoneira Q1 2024 Adj EPS $(0.180) Beats $(0.270) Estimate, Sales $39.731M Miss $40.581M Estimate

AFCG

ALIM

AMTX

AOUT

ARBE

ARCT

ARHS

ASLE

ASPS

AVGO

BBAI

BBCP

BILI

BITF

BNED

BURL

CHMI

CIEN

CINT

CLAR

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

COOK

COST

CTOS

DBVT

DLTH

DOCU

DOMO

DSGR

DXPE

ELUT

EOLS

EVGN

EYPT

FCEL

FNKO

GEVO

GIFI

GRND

GRNT

GWRE

HBIO

ISDR

JYNT

LCTX

LOCO

LUMO

LVRO

METC

MGNX

MKFG

MRVL

NAPA

NCSM

NDLS

NEPH

NINE

ONCT

ONCY

OPFI

OPTN

OWLT

PBPB

PHAT

PMTS

PRCH

PowerShares Dynamic Industrials Sector Portfolio

PROF

PRTS

PSFE

RDVT

REAX

REFR

RWAY

SDPI

SGHT

Earnings Scheduled For March 7, 2024

Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) is set to give its latest quarterly earnings report on Thursday, 2024-03-07. Here's what investors need to know before the announcement.
Analysts estimate that Limoneira will report an earnings per share (EPS) of $-0.29. 
Limoneira bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Past Earnings Performance</h3>
Last quarter the company missed EPS by $0.00, which was followed by a 6.88% increase in the share price the next day.
Here's a look at Limoneira's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.15</td>
<td>0.15</td>
<td>0.19</td>
<td>-0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.15</td>
<td>0.02</td>
<td>0.21</td>
<td>-0.53</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-4.0%</td>
<td>-8.0%</td>
<td>5.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1709744541_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Limoneira were trading at $17.91 as of March 05. Over the last 52-week period, shares are up 13.13%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/LMNR/earnings">To track all earnings releases for Limoneira visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Limoneira

Roth MKM analyst Gerry Sweeney maintains Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>) with a Buy and raises the price target from $17 to $23.

Roth MKM Maintains Buy on Limoneira, Raises Price Target to $23

Thursday marks the last chance for investors to receive the next dividend payout from Limoneira (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMNR#NASDAQ">LMNR</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 7.5 cents per share. On Friday, Limoneira will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 7.5 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own LMNR as of the end of Thursday's session are eligible to receive the 7.5 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 12, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/LMNR">See current stock movements Limoneira on Benzinga.</a>

Dividends

Limoneira: Dividend Insights

Riverwater Micro Opportunities Strategy Q2 2024 Commentary

Limoneira Co (LMNR) has issued an announcement. Limoneira Company's Board of Directors has established Change in Control Agreements for key executi...

Limoneira Co Ensures Executive Stability Amidst Takeover Possibilities

An update from Limoneira Co (LMNR) is now available. Limoneira Company has entered into Transaction Bonus Agreements with its executive officers, p...

Limoneira Co Incentivizes Executives for Successful Company Sale

In a report released today, Ben Klieve from Lake Street maintained a Buy rating on Limoneira Co (LMNR – Research Report), with a price target of $2...

Lake Street Sticks to Their Buy Rating for Limoneira Co (LMNR)

Earnings week ahead: Adobe, Oracle, Kroger, GameStop and more

Limoneira Company Non-GAAP EPS of $0.42 beats by $0.08, revenue of $63.31M misses by $0.26M

Limoneira Company (LMNR) Q3 2024 Earnings Call Transcript

Limoneira: A Unique Business Still Going Strong

Limoneira Company declares $0.075 dividend

Fresh Del Monte: Under The Radar, Long-Term Dividend Investors May Love This One

Comments

Limoneira

Notizie

Ultime notizie per Limoneira (NASDAQ:LMNR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO